Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels

International Journal of Cancer

Volumn 123, Issue 4, 2008, Pages 917-926

  Yanaoka, Kimihiko ^a   Oka, Masashi ^a   Yoshimura, Noriko ^b   Mukoubayashi, Chizu ^a   Enomoto, Shotaro ^a   Iguchi, Mikitaka ^a   Magari, Hirohito ^a   Utsunomiya, Hirotoshi ^a   Tamai, Hideyuki ^a   Arii, Kenji ^a   Yamamichi, Nobutake ^b   Fujishiro, Mitsuhiro ^b   Takeshita, Tatsuya ^a   Mohara, Osamu ^c   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Wakayama Wellness Foundation   (Japan)

Author keywords

Chronic atrophic gastritis; Gastric cancer; Helicobacter pylori; Intestinal metaplasia; Pepsinogen

Indexed keywords

ANTIBODY; PEPSINOGEN; BACTERIUM ANTIBODY;

ADULT; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; GASTRITIS; HAZARD RATIO; HELICOBACTER PYLORI; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; HELICOBACTER INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; JAPAN; LONGITUDINAL STUDY; MICROBIOLOGY; MIDDLE AGED; STOMACH TUMOR;

ADULT; ANTIBODIES, BACTERIAL; COHORT STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; LONGITUDINAL STUDIES; MIDDLE AGED; PEPSINOGEN A; RISK FACTORS; STOMACH NEOPLASMS;

EID: 47049086045     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23571     Document Type: Article

References (66)

1. Correa P. Human gastric carcinogenesis: a multi-step and multi-factorial process. First American Cancer Society Award Lecture on Cancer Epidemiology Prevention. Cancer Res 1992;52:6735-40.
2. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991;302:1302-5.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
4. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among. Japanese. Americans in. Hawaii. N Engl J Med 1991;325:1132-6.
5. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991;83:1734-9.
6. Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992;45:319-23.
7. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62
8. International Agency for Research on Cancer. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240
9. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cag A is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-15.
10. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
11. Danesh J. Is Helicobacter pylori a cause of gastric neoplasia? In: Newton R, Beral V, Weiss RA, eds. Infections and human cancer, cancer surveys, 33. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999. 263-90.
12. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
13. Ottenjann R, Miederer S, Elster K, Stadelmann O, Rettenmaier G. Zangenbiopsie aus dem antrum-, korpus- und Kardiabereich des Magens unter endoskopischer kontrolle. Klin Wschr 1969;47:859-61.
14. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-92.
15. Tatsuta M, Saegusa T, Okuda SH. Studies on gastritis in the upper portion of stomach by endoscopic Congo red test. Endoscopy 1973;5:61-9.
16. Siurala M, Varis K, Wiljasalo M. Studies on patients with atrophic gastritis: a 10-15 year follow-up. Scand J Gastroenterol 1966;1:40-8.
17. Meister H, Holubarsch CH, Haferkamp C, Schlag P, Herfarth CH. Gastritis, intestinal metaplasia and dysplasia versus benign gastric ulcer in stomach and duodenum and gastric carcinoma: a histotopographic study. Path Res Pract 1979;164:259-69.
18. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
19. Testoni PA, Masci E, Marchi R, Guslandi M, Ronchi G, Tittobello A. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk. J Clin Gastroenterol 1987;9:298-302.
20. Tatsuta M, Iishi H, Nakaizumi A, Okuda S, Taniguchi H, Hiyama T, Tsukuma H, Oshima A. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993;53:70-4.
21. Plummer M, Buiatti E, Lopez G, Peraza S, Vivas J, Oliver W, Munoz N. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol 1997;26:716-20.
22. Guarner J, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, Parsonnet J. Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol 1999;30:1431-4.
23. Hirschowitz BI. Pepsinogen: its origin, secretion, and excretion. Physiol Rev 1957;37:475-511.
24. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosa histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
25. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
26. Nomura AM, Stemmermann GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980;93:537-40.
27. Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarker Prev 1993;2:461-6.
28. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
29. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-8.
30. Knekt P, Teppo L, Aromaa A, Rissanen H, Kosunen TU. Helicobacter pylori Ig. A and. Ig. G antibodies, serum pepsinogen. I and the risk of gastric cancer: changes in the risk with extended follow-up period. Int J Cancer 2006;119:702-5.
31. Nardone G, Rocco A, Malfertheiner P. Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004;20:261-70.
32. Correa P. Does. Helicobacter pylori cause gastric cancer via oxidative stress? Bio Chem 2006;387:361-4.
33. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M. Helicobacter pylori infection enhances glandular stomach carcinogenesis in. Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999;20:669-76.
34. Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, Kumagai T, Sugiyama A, Mizoshita T, Kaminishi M, Tatematsu M. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002;93:1083-9.
35. Eaton KA, Krakowka S. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterol 1992;103:1580-6.
36. Loffeld RJ, Werdmuller BF, Kusters JG, Kuipers EJ. IgG antibody titer against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H. pylori strains. FEMS Immunol Med Microbiol 2000;28:139-41.
37. Ichinose M, Miki K, Furihata C, Kageyama T, Hayashi R, Niwa H, Oka H, Matsushima T, Takahashi K. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982;126:183-91.
38. Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, Ozasa K, Kawai K. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997;42:1383-7.
39. Ichinose M, Yahagi N, Oka M, Ikeda H, Miki K, Omata M. Screening for gastric cancer in Japan. In: Wu GY, Aziz K, eds. Cancer screening for common malignancies. Totowa, New Jersey: Humana Press, 2001. 87-102
40. Chen TS, Chang FY, Lee SD. Serodiagnosis of Helicobacter pylori infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results. J Clin Microbiol 1997;35:184-6.
41. Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Tamai H, Arii K, Nakata H, et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005;96:713-20.
42. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
43. Kuipers EJ, Gracia-Casanova M, Pena AS, Pals G, Van Kamp G, Kok A, Kurz-Pohlmann E, Pels NF, Meuwissen SG. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993;28:433-7.
44. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M. Weak response of Helicobacter pylori antibody is high risk for gastric cancer: a cross-sectional study of 10,234 endoscoped Japanese. Scand J Gastroenterol 2002;37:148-53.
45. Magari H, Shimizu Y, Inada K, Enomoto S, Tomeki T, Yanaoka K, Tamai H, Arii K, Nakata H, Oka M, Utsunomiya H, Tsutsumi Y, el al. Inhibitory effect of ctodolac, a selective cycloxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian cerbils. Biochem Biophys Res Commun 2005;334:606-12.
46. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
47. Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N. Helicobacter pylori infection in combination with the serum pepsinogen. I/II ratio and interleukin-1β-511 polymorphisms are independent risk factors for gastric cancer in Thais. J Gastroenterol 2006;41:1169-77.
48. Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Walsh JH. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterol 1991;101:167-74.
49. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, Virlamo J, Haapiainen R, Rautelin H. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-24.
50. Ning PF, Liu HJ, Yuan Y. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol 2005;11:2545-8.
51. Plebani M, Basso D, Cassro M. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996;91:954-8.
52. Mardh E, Mardh S, Mardh B, Borch K. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002;320:17-27.
53. Gisbert JP, Boixeda D, Vila T. Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment? Med Clin (Barc) 1995;105:561-5.
54. Pilotto A, Dimario F, Franceschi M. Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. Aliment Pharmacol Ther 1996;10:1021-7.
55. Kawai T, Miki K, Ichinose M, Kenji Y, Miyazaki I, Kawakami K, Kataoka M, Yamagishi T, Sofuni A, Itoi T, Moriyasu F, Takagi Y, et al. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan. Inflammopharmacol 2007;15:31-5.
56. Correa P. Precursors of gastric and esophageal cancer. Cancer 1982;50:2554-65.
57. Lauren P. Histogenesis of intestinal and diffuse types of gastric carcinoma. Scand J Gastroenterol 1991;26 (suppl 180):160-4.
58. Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methvlation along the multistep pathway of gastric carcinogenesis. Lab invest 2003;83:635-41.
59. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. Promoter methylation of E-cadhcrin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003;52:502-6.
60. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae, and its possible association with gastric cancer risk. Clin Cancer Res 2006;12:989-95.
61. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinoma. J Natl Cancer Inst 2000;92:16-7.
62. Sipponen P, Harkonen M, Alanko A, Suovanieml O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002;48:505-15.
63. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila A, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test, correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
64. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komolo K, Tanaka S, Kajiyama G. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998;93:1090-6.
65. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrarions. Gut 1999;4:693-7.
66. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Digest Dis 2007;8:15-22.